Showing results (351-360 of 909) with videos related to
Sort By:
Pageof 91
The American Journal of Medicine|August 14, 2021
Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 SyndromeMarcus Ståhlberg, Ulrika Reistam, Artur Fedorowski, et al.European Heart Journal|July 19, 2013
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trialTimothy J Collier, Stuart J Pocock, John J V McMurray, et al.Circulation|October 9, 2012
Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizationsJennifer K Rogers, John J V McMurray, Stuart J Pocock, et al.Hypertension (Dallas, Tex. : 1979)|June 19, 2008
History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failureBertram Pitt, Ali Ahmed, Thomas E Love, et al.Journal of Diabetes and Its Complications|February 12, 2026
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITYRobert Weingold, Gerasimos Filippatos, Stefan D Anker, et al.European Journal of Heart Failure|June 27, 2023
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS-HF trialLuca Monzo, Nicolas Girerd, Kevin Duarte, et al.Circulation. Heart Failure|June 15, 2021
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF TrialJoão Pedro Ferreira, Zohra Lamiral, John J V McMurray, et al.European Journal of Heart Failure|January 11, 2020
Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunctionPatrick Rossignol, Kevin Duarte, Nicolas Girerd, et al.Journal of the American College of Cardiology|August 3, 2019
Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection FractionAwais Malik, Ravi Masson, Steven Singh, et al.Journal of Clinical Pharmacology|April 13, 2018
An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675Bertram Pitt, Vanessa Zann, Chris Roe, et al.Pageof 91